Mabloc’s pipeline reflects our progress across various therapeutic areas. With our BRAID™ platform we’ve already made advances in infectious diseases like dengue, yellow fever, and COVID-19. We are now expanding our focus to include chronic conditions such as diabetes and autoimmune disorders. Using AI and bioinformatics, we are developing antibodies for a wide range of diseases, offering more impactful approaches to improve global health.
.jpg)
"At Mabloc, we’re focused on one thing: making sure our therapies reach people as soon as possible. With BRAID™, we’re not waiting around for years—we’re pushing to get life-saving treatments into the hands of those who need them, now. I always tell my team, ‘We’re doing this today, not in some distant future.’ That’s what drives us every day.”
